Literature DB >> 19575688

Performance characteristics of postpartum screening tests for type 2 diabetes mellitus in women with a history of gestational diabetes mellitus: a systematic review.

Wendy L Bennett1, Shari Bolen, Lisa M Wilson, Eric B Bass, Wanda K Nicholson.   

Abstract

BACKGROUND: Women with a history of gestational diabetes mellitus are at high risk for type 2 diabetes mellitus. We systematically reviewed and synthesized the literature on the sensitivity, specificity, and reproducibility of postpartum screening tests for type 2 diabetes in women with prior gestational diabetes to inform screening guidelines.
METHODS: We searched electronic databases through October 1, 2008. Two investigators independently reviewed titles, abstracts, and articles, performed serial data abstraction, and independently assessed quality. We calculated standard errors and confidence intervals for sensitivity and specificity using the exact binomial formula.
RESULTS: Eleven studies contained 13 evaluations of a comparison screening test with the 2-h 75-g oral glucose tolerance test (OGTT) reference. All studies used a cross-sectional study design. There were ten comparisons of a single fasting blood glucose (FBG) >=7.0 mmol/L (>=126 mg/dL) with the OGTT. The sensitivity ranged from 14%-100% in five studies using the 1985 World Health Organization's (WHO) criteria as the reference and from 16%-89% in five studies using the 1999 WHO criteria as the reference. Variation in the sensitivities may be due to the limited number of comparisons, differences in populations, and timing of screening. There were high losses to follow-up, limiting generalizability.
CONCLUSIONS: When compared with the OGTT, the single FBG alone was not consistently reported to be a sensitive screening test for type 2 diabetes in women with a history of gestational diabetes. Longitudinal studies are needed to address the natural history of glucose metabolism in women with a history of gestational diabetes, the optimal approach to diagnostic testing for type 2 diabetes in this population, and the short-term and long-term outcomes of testing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19575688      PMCID: PMC2789183          DOI: 10.1089/jwh.2008.1132

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  35 in total

1.  Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus.

Authors:  Catherine Kim; Bahman P Tabaei; Ray Burke; Laura N McEwen; Robert W Lash; Susan L Johnson; Kendra L Schwartz; Steven J Bernstein; William H Herman
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

2.  Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus.

Authors:  Boyd E Metzger; Thomas A Buchanan; Donald R Coustan; Alberto de Leiva; David B Dunger; David R Hadden; Moshe Hod; John L Kitzmiller; Siri L Kjos; Jeremy N Oats; David J Pettitt; David A Sacks; Christos Zoupas
Journal:  Diabetes Care       Date:  2007-07       Impact factor: 19.112

Review 3.  Gestational diabetes after delivery. Short-term management and long-term risks.

Authors:  John L Kitzmiller; Leona Dang-Kilduff; M Mark Taslimi
Journal:  Diabetes Care       Date:  2007-07       Impact factor: 19.112

4.  Increasing prevalence of gestational diabetes mellitus: a public health perspective.

Authors:  Assiamira Ferrara
Journal:  Diabetes Care       Date:  2007-07       Impact factor: 19.112

5.  Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005.

Authors:  Jean M Lawrence; Richard Contreras; Wansu Chen; David A Sacks
Journal:  Diabetes Care       Date:  2008-01-25       Impact factor: 19.112

6.  The importance of a postpartum 75 g oral glucose tolerance test in women with gestational diabetes.

Authors:  Shauna L Reinblatt; Lucie Morin; Sara J Meltzer
Journal:  J Obstet Gynaecol Can       Date:  2006-08

7.  Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus.

Authors:  Catherine Kim; William H Herman; Sandeep Vijan
Journal:  Diabetes Care       Date:  2007-02-23       Impact factor: 19.112

8.  Postpartum diabetes screening in women with a history of gestational diabetes.

Authors:  Karen V Smirnakis; Lisa Chasan-Taber; Myles Wolf; Glenn Markenson; Jeffrey L Ecker; Ravi Thadhani
Journal:  Obstet Gynecol       Date:  2005-12       Impact factor: 7.661

9.  Mortality trends in men and women with diabetes, 1971 to 2000.

Authors:  Edward W Gregg; Qiuping Gu; Yiling J Cheng; K M Venkat Narayan; Catherine C Cowie
Journal:  Ann Intern Med       Date:  2007-06-18       Impact factor: 25.391

10.  Who returns for postpartum glucose screening following gestational diabetes mellitus?

Authors:  Kelly J Hunt; Deborah L Conway
Journal:  Am J Obstet Gynecol       Date:  2008-02-01       Impact factor: 8.661

View more
  5 in total

1.  High priority research needs for gestational diabetes mellitus.

Authors:  Wendy L Bennett; Karen A Robinson; Ian J Saldanha; Lisa M Wilson; Wanda K Nicholson
Journal:  J Womens Health (Larchmt)       Date:  2012-07-02       Impact factor: 2.681

2.  Diabetes screening after gestational diabetes in England: a quantitative retrospective cohort study.

Authors:  Andrew McGovern; Lucilla Butler; Simon Jones; Jeremy van Vlymen; Khaled Sadek; Neil Munro; Helen Carr; Simon de Lusignan
Journal:  Br J Gen Pract       Date:  2014-01       Impact factor: 5.386

3.  Maternal Race/Ethnicity and Postpartum Diabetes Screening: A Systematic Review and Meta-Analysis.

Authors:  Cynthia J Herrick; Ritika Puri; Rana Rahaman; Angela Hardi; Karyn Stewart; Graham A Colditz
Journal:  J Womens Health (Larchmt)       Date:  2020-02-19       Impact factor: 2.681

Review 4.  Postpartum screening for diabetes among women with a history of gestational diabetes mellitus.

Authors:  Alison Tovar; Lisa Chasan-Taber; Emma Eggleston; Emily Oken
Journal:  Prev Chronic Dis       Date:  2011-10-17       Impact factor: 2.830

5.  Validity of meta-analysis in diabetes: meta-analysis is an indispensable tool in evidence synthesis.

Authors:  Sherita Hill Golden; Eric B Bass
Journal:  Diabetes Care       Date:  2013-10       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.